Michael G. G Brandel

Dr. Michael G. G Brandel


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Radiology
Verified
Journal Article
Closed access
PAPeter Abraham
Peter Abraham
RSReith Sarkar
Reith Sarkar
MBMichael G. G Brandel
Michael G. G Brandel
AWArvin R. Wali
Arvin R. Wali
RRRobert C. Rennert
Robert C. Rennert
AKAlexander A. Khalessi
Alexander A. Khalessi
A microsimulation model of intraoperative MRI was constructed to record quality of life and treatment costs for patients with high-grade glioma from initial tumor resection until death. Intraoperat... Background Intraoperative MRI has been shown to improve gross-total resection of high-grade glioma. However, to the knowledge of the authors, the cost-effectiveness of intraoperative MRI has not be...

1 May 2020 in World Neurosurgery
Verified
Journal Article
Closed access
ACAnkush Chandra
Ankush Chandra
MBMichael G. G Brandel
Michael G. G Brandel
HWHarsh Wadhwa
Harsh Wadhwa
NANeil D. Almeida
Neil D. Almeida
John K YueJohn K Yue
John K Yue
MAManish K. Aghi
Manish K. Aghi

31 December 2023 in Journal of Cerebrovascular and Endovascular Neurosurgery
Verified
Journal Article
Open access
PDF file
CMCarson P. McCann
Carson P. McCann
MBMichael G. G Brandel
Michael G. G Brandel
AWArvin R. Wali
Arvin R. Wali
JSJeffrey A. Steinberg
Jeffrey A. Steinberg
JPJ. Scott Pannell
J. Scott Pannell
AKAlexander A. Khalessi
Alexander A. Khalessi
Objective: Middle meningeal artery embolization (MMAe) has burgeoned as a treatment for chronic subdural hematoma (cSDH). This study evaluates the safety and short-term outcomes of MMAe patients relative to traditional treatment approaches.Methods: In this retrospective large database study, adult patients in the National Inpatient Sample from 2012-2019 with a diagnosis of cSDH were identified. Cost of admission, length of stay (LOS), discharge disposition, and complications were analyzed. Propensity score matching (PSM) was utilized.Results: A total of 123,350 patients with cSDH were identified: 63,450 without intervention, 59,435 surgery only, 295 MMAe only, and 170 surgery plus MMAe. On PSM analysis, MMAe did not increase the risk of inpatient complications or prolong the length of stay compared to conservative management (p>0.05); MMAe had higher cost ($31,170 vs. $10,768, p<0.001) than conservative management, and a lower rate of nonroutine discharge (53.8% vs. 64.3%, p=0.024). Compared to surgery, MMAe had shorter LOS (5 vs. 7 days, p<0.001), and lower rates of neurological complications (2.7% vs. 7.1%, p=0.029) and nonroutine discharge (53.8% vs. 71.7%, p0.05).Conclusions: MMAe had similar LOS and decreased odds of adverse discharge with a modest cost increase compared to conservative management. There was no difference in inpatient complications. Compared to surgery, MMAe treatment was associated with decreased LOS and rates of neurological complications and nonroutine discharge. This nationwide analysis supports the safety of MMAe to treat cSDH.

22 July 2022 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
KWKarol Wiśniewski
Karol Wiśniewski
MBMichael G. G Brandel
Michael G. G Brandel
DGDavid D. Gonda
David D. Gonda
John Ross CrawfordJohn Ross Crawford
John Ross Crawford
MLMichael L Levy
Michael L Levy

10 March 2018 in Cureus
Verified
Journal Article
Open access
PDF file
VCVincent J. Cheung
Vincent J. Cheung
AWArvin R. Wali
Arvin R. Wali
DSDavid R. Santiago-Dieppa
David R. Santiago-Dieppa
RRRobert C. Rennert
Robert C. Rennert
MBMichael G. G Brandel
Michael G. G Brandel
AKAlexander A Khalessi
Alexander A Khalessi
Introduction: Delays in door to groin puncture time (DGPT) for patients with ischemic stroke caused by acute large vessel occlusions (LVO) are associated with worse clinical outcomes. We present the results of a quality improvement protocol for endovascular stroke treatment at the University of California, San Diego (UCSD) that aimed to minimize DGPT. Materials and Methods: Our stroke team implemented a series of quality improvement measures to decrease DGPT, with a target of 90 minutes or less. Sixty-three patients treated at our center were retrospectively divided into three groups based on the date of their intervention as a proxy for the implementation of process improvement protocols: 23 patients treated from July to December 2015, 24 patients treated from January to July 2016, and 16 patients treated from July 2016 to December 2016. Multivariate log-linear and logistic regression analyses were used to assess the predictors of prolonged DGPT and compliance with target DGPT (<90 min), respectively. Results: Date of intervention—a proxy for the implementation of process improvement protocols—was predictive of compliance with target DGPT. Patients treated from July 2016 to December 2016—after the full implementation of process improvements—were 3.2 times more likely to meet or exceed the target DGPT compared to patients treated from July 2015 to December 2015 (p=0.011). When adjusting for potential confounders in a multivariate analysis, patients in the final cohort were associated with shorter DGPT (Exp(B)=0.61, p=0.013) and remained significantly more likely to achieve the DGPT goal (OR=14.2, p=0.007). Conclusion: An iterative quality improvement process can significantly improve DGPT. This analysis demonstrates the utility of a formal quality improvement system at an academic comprehensive stroke center.

6 August 2022 in World Neurosurgery
Verified
Journal Article
Closed access
MAMohammad Azab
Mohammad Azab
NGNicholas Gamboa
Nicholas Gamboa
JNJeffrey Nadel
Jeffrey Nadel
CCChristopher Cutler
Christopher Cutler
JHJeffrey Curran Henson
Jeffrey Curran Henson
MKMichael Karsy
Michael Karsy